Munjal-Burmans bat for level playing field in Fortis bidding
New Delhi: Hero Enterprise and Burman Family Office said that equal opportunity should be provided to all the parties involved in the bidding of Fortis Healthcare.
"We have just heard about the announcement made by Fortis and are a bit surprised as we had assumed that the final bids were submitted and the process now was only to review and choose the best offer," Sunil Kant Munjal said on the behalf of himself, Mohit Burman and Anand Burman in a statement.
The committee will evaluate all binding bids received by the company from any party except Manipal and TPG consortium till 12 noon on May 1.
"In line with the obligations towards Manipal and TPG consortium, Manipal and TPG consortium will have the ability to provide a revised financial proposal till 12 noon on May 06, 2018 in relation to all binding bids received by the company anytime till 12 noon on May 1, 2018," Fortis Healthcare had earlier said in a regulatory filing.
The filing had further said: "In light of the above, EAC constituted by the Board of the company will evaluate all binding bids received from any party till 12 noon on May 01, 2018 and the revised binding financial proposals from the Manipal and TPG Consortium received till 12 noon on May 6, 2018."
Munjal-Burmans said they still welcome the move by the Fortis and hoped that the FHL board will repose their confidence in their bid.
"Our offer is already the best one and in the larger interest of Fortis Healthcare, and all those connected with the company's ecosystem- its shareholders, patients, their attendants, doctors, the community and public at large, beside lenders, suppliers, medical and non-medical staff," Munjal said.
The entity is keen to invest directly in the company and believe this is the best way to create value for all stakeholders, he added.
FHL has already received binding offers from four entities - KKR-backed Radiant Life Care, Malaysian major IHH Healthcare, Manipal/TPG consortium and Munjal and Burman family offices.